Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2003
04/03/2003CA2820144A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003CA2469230A1 Antibody inhibitors of gdf-8 and uses thereof
04/03/2003CA2461853A1 Anti-fusion assay
04/03/2003CA2461631A1 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
04/03/2003CA2461529A1 Recombinant anti-osteopontin antibody and use thereof
04/03/2003CA2461454A1 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
04/03/2003CA2461413A1 Printed materials comprising a support having an oligomer and/or a polymer applied thereon, a method for preparing the same and a method for delivering and/or storing the same
04/03/2003CA2461372A1 Dna sequences for human angiogenesis genes
04/03/2003CA2461305A1 Methods of suppressing microglial activation and systemic inflammatory responses
04/03/2003CA2461186A1 Novel screening method using prokineticin receptor
04/03/2003CA2461094A1 P300 histone acetylase inhibitor
04/03/2003CA2461010A1 Method of synthesizing polynucleotide via reverse translation from protein and oligonucleotide to be used in this method
04/03/2003CA2461003A1 Human coagulation factor vii polypeptides
04/03/2003CA2460953A1 Proteins associated with cell growth, differentiation, and death
04/03/2003CA2460872A1 A method for providing and inhibiting the rice fertility, and discerning the presence of the rice restorer gene by using the rice restorer gene to the rice bt type cytoplasmic male sterility
04/03/2003CA2460780A1 Autologous growth factor cocktail composition, method of production and use
04/03/2003CA2460541A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
04/03/2003CA2459999A1 Antagonists_and agonists of igf-1 receptor
04/03/2003CA2459827A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003CA2459807A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003CA2455117A1 Enzyme phosphorylating ser46 of p53
04/03/2003CA2453985A1 Receptors and membrane-associated proteins
04/02/2003EP1298436A2 Beta-amyloid peptide (BAP) release inhibitor compounds for treating BAP-related diseases and methods for their identification
04/02/2003EP1298215A2 Recombinant production of immunologically reactive truncated CMV glycoprotein H
04/02/2003EP1298212A2 Method for cloning and expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli and purification of BsmBI endonuclease
04/02/2003EP1298211A2 Polynucleotide segment of HPV16 Genome
04/02/2003EP1298210A1 Cocoa flavour precursor peptides
04/02/2003EP1298209A1 Novel transcription factor having zinc finger domains
04/02/2003EP1298203A2 Diagnosis and treatment of autoimmune diseases
04/02/2003EP1298202A2 Biological factors and neural stem cells
04/02/2003EP1298144A2 Murine monoclonal anti-idiotype antibody 3H1
04/02/2003EP1298143A1 44590, A human ABC transporter family member and uses therefor
04/02/2003EP1298140A2 Mutants of bone morphogenetic proteins (BMP)
04/02/2003EP1297845A2 Toxoid of dermonecrotic toxin produced by bordetella
04/02/2003EP1297844A2 Multicomponent meningococcal vaccine
04/02/2003EP1297842A1 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
04/02/2003EP1297841A1 Pancreatic langerhans beta cell proliferation promoter and apoptosis inhibitor, and screening of candidate compounds for the e drugs
04/02/2003EP1297335A2 Process for the measurement of dinophysistoxin and of yessotoxin
04/02/2003EP1297185A2 Diagnosis of diseases associated with signal transduction
04/02/2003EP1297182A2 Diagnosis of diseases associated with cell signalling
04/02/2003EP1297180A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
04/02/2003EP1297166A2 Chimeric promoters for controlling expression in smooth muscle cells
04/02/2003EP1297162A1 Elicitor from cladosporium
04/02/2003EP1297161A2 Methods and means for regulation of gene expression
04/02/2003EP1297160A1 Materials and methods relating to the increase in protein activity
04/02/2003EP1297147A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
04/02/2003EP1297145A2 Streptococcus pyogenes antigen
04/02/2003EP1297144A1 Recombinant saccharomyces cerevisiae expressing chimeric glucose transporters
04/02/2003EP1297143A2 Esr1 -a plant gene that can promote plant regeneration and transformation
04/02/2003EP1297140A2 Regulation of human p2y8-like g protein-coupled receptor
04/02/2003EP1297139A2 G-protein coupled receptor org10
04/02/2003EP1297138A2 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof
04/02/2003EP1297136A2 Full length human hcn1 ih channel subunit and variants
04/02/2003EP1297135A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor
04/02/2003EP1297134A2 Novel human gaba receptors and polynucleotides encoding the same
04/02/2003EP1297133A2 Gp354 nucleic acids and polypeptides
04/02/2003EP1297132A1 A novel app mutation associated with an unusual alzheimer's disease pathology
04/02/2003EP1297131A2 Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods
04/02/2003EP1297130A2 G-protein coupled receptors
04/02/2003EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
04/02/2003EP1297128A2 G-protein coupled receptors
04/02/2003EP1297127A2 Gpr22 modulators as appetite-control agents
04/02/2003EP1297126A1 Nucleotide and amino acid sequences of a cellular inhibitor of the dna replication in the epstein-barr herpes virus
04/02/2003EP1297125A2 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
04/02/2003EP1297118A1 Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen
04/02/2003EP1297114A1 NUCLEIC ACID MOLECULES ENCODING A PROTEIN INTERACTING WITH Ser/Thr KINASE Akt
04/02/2003EP1297113A2 Cyanobacterial nucleic acid fragments encoding proteins useful for controlling plant traits via nuclear or plastome transformation
04/02/2003EP1297110A1 Attenuated bovine respiratory syncytial virus
04/02/2003EP1297109A1 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
04/02/2003EP1297108A2 Cell lines and cell-based assays for identification of androgen receptor modulators
04/02/2003EP1297015A1 Structure based drug design method to identify compounds that bind to cd81, a cell receptor for hepatitis-c
04/02/2003EP1297014A2 Transporters and ion channels
04/02/2003EP1297013A2 Use of taci as an anti-tumor agent
04/02/2003EP1297012A2 Novel fibroblast growth factors and nucleic acids encoding same
04/02/2003EP1297011A1 The t-cell protein tzon7, peptides and antibodies derived therefrom and uses thereof
04/02/2003EP1297010A2 Bioelastomer nanomachines and biosensors
04/02/2003EP1297009A2 Tumor-associated antigen b132
04/02/2003EP1297008A2 Cerebellin homologous polypeptides and therapeutic uses thereof
04/02/2003EP1297005A2 Immunisation against chlamydia pneumoniae
04/02/2003EP1297003A2 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS
04/02/2003EP1297002A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery
04/02/2003EP1296998A2 Hcv variants
04/02/2003EP1296718A1 Pharmaceutical composition of modified pna molecules
04/02/2003EP1296712A2 Hiv-1 vaccines and screening methods therefor
04/02/2003EP1296710A1 Recombinant vaccines against infectious bursal disease virus
04/02/2003EP1296709A1 Solubilised protein vaccines
04/02/2003EP1296707A1 Methods of treating viral diseases with il-18 and il-18 combinations
04/02/2003EP1296704A2 Peptides with physiological activity
04/02/2003EP1296702A1 Neuroprotective peptides
04/02/2003EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
04/02/2003EP1171451A4 Separation of plasma components
04/02/2003EP1141301A4 Sequence-determined dna fragments and corresponding polypeptides encoded thereby
04/02/2003EP1135145B1 Isolated material having an anti-organotrophic effect
04/02/2003EP1092038A4 OCT1p, A PROTEIN HAVING HOMOLOGY TO THE ORGANIC AND SUGAR TRANSPORTER FAMILY OF PROTEINS, AND USES THEREOF
04/02/2003EP1080206B1 Generation of multiple gene products from chimeric fusion proteins by cleavage with endoproteases
04/02/2003EP0920629B1 Western blot test for the identification of antibodies specific against the hcmv virus
04/02/2003EP0871464B1 Bradykinin analogs as selective thrombin inhibitors
04/02/2003EP0865445B1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
04/02/2003EP0831900B1 Methods of raising antibodies against e.coli of the family cs4-cfa/1
04/02/2003EP0830380B1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof